Middle East IVD Market 2017-2022: Focus on Clinical Chemistry, Immunoassay, Microbiology, Point-of-Care & Histology Markets - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Aug 22, 2018--The “The IVD Market in the Middle East” report has been added to ResearchAndMarkets.com’s offering.
This report on the Middle East IVD in the last five years finds the Middle East remains as an underserved region with large market potential.
Many Middle Eastern countries, such as Saudi Arabia, have identified investment in healthcare infrastructure as a priority, the goal to expand healthcare beyond cities and into desert communities; today roughly 16% of the population is represented by rural areas of the country.
The region’s public sector has historically dominated the delivery of healthcare in the Middle East; however, recent activity from governments in the region approaching investors to expand the private sector in health care continues to be encouraging. This is a strategy to diversify and reduce some dependence on the petroleum industry as oil prices continue to be strained. Countries in the region need to create systems that empower the private sector to participate more deeply in the healthcare system. Growth in private sector participation will improve the quality of health care and access to it.
Some of the total IVD market growth derives from increased test usage in emerging countries. All of the major IVD companies have reported growth in Turkey and Saudi Arabia considered two of the top seven emerging markets. These countries continue to invest in healthcare infrastructure and insurance coverage for a growing more affluent middle class.
This development requires increased investment in healthcare. This increased investment most often takes the form of government tenders, which remain a major source of supply for state-controlled labs and hospitals. Lifestyle change a more sedentary lifestyle resulting in rising obesity rates has brought about the emergence of Western diseases such as diabetes. There is growing demand in the region, therefore, for medical tests.
Key Topics Covered:
1. Executive SummaryOverview Scope and Methodology Size and Growth of the Market
2. Middle East: Regional OverviewPopulation Economic Outlook Major Diseases Affecting the Middle Eastern Population Cardiovascular Diseases Cancer Diabetes Middle Eastern Respiratory Syndrome (MERS) Arab Health Congress
3. Country Market Analysis
4. Market Summary: Total Middle East MarketSummary Clinical Chemistry Market Immunoassay Market Microbiology Market Point-of-Care Market Histology Market
For more information about this report visit https://www.researchandmarkets.com/research/xpqmhx/middle_east_ivd?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180822005297/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:In Vitro Diagnostics
KEYWORD: MIDDLE EAST
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/22/2018 06:46 AM/DISC: 08/22/2018 06:46 AM